Thomas Pearse Lyons

US Patent:

20070122491, May 31, 2007

Filed:

Oct 16, 2006

Appl. No.:

11/581282

Inventors:

Thomas Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

Alltech, Inc. - Nicholasville KY

International Classification:

A61K 38/28
A61K 38/22
A61K 33/26
A61K 33/04
A61K 31/426
A61K 31/155
A61K 31/17

US Classification:

424702000, 514003000, 514012000, 514369000, 514594000, 514635000, 424646000

Abstract:

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

US Patent:

20070155687, Jul 5, 2007

Filed:

Oct 16, 2006

Appl. No.:

11/581535

Inventors:

Thomas Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

Alltech, Inc. - Nicholasville KY

International Classification:

A61K 48/00
A61K 31/198
A61K 31/433
A61K 31/4704
A61K 31/473
A61K 31/445
A61K 31/55
A61K 31/355
A61K 31/375
A61K 31/135
A61K 31/13
A61K 31/095

US Classification:

514044000, 514561000, 514662000, 514458000, 514474000, 514312000, 514646000, 514706000, 514362000, 514214030, 514319000, 514297000, 514185000, 514731000

Abstract:

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

US Patent:

20080004255, Jan 3, 2008

Filed:

Oct 16, 2006

Appl. No.:

11/581682

Inventors:

Thomas Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

Alltech, Inc. - Nicholasville KY

International Classification:

A61K 31/095
A61K 31/13
A61K 31/136
A61K 31/198
A61K 31/355
A61K 31/385
A61K 31/41
A61K 31/433
A61K 31/445
A61K 31/47
A61K 31/473
A61K 31/55
A61P 25/28

US Classification:

514215000, 514297000, 514311000, 514319000, 514363000, 514441000, 514458000, 514474000, 514562000, 514646000, 514658000, 514662000, 514706000

Abstract:

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

US Patent:

20080008692, Jan 10, 2008

Filed:

Oct 16, 2006

Appl. No.:

11/581243

Inventors:

Thomas Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

Alltech, Inc. - Nicholasville KY

International Classification:

A61K 33/04
A61K 33/34
A61K 36/06
A61P 25/14
A61P 25/16
A61P 25/28

US Classification:

424093510, 424630000, 424702000

Abstract:

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

US Patent:

20080107755, May 8, 2008

Filed:

Apr 24, 2007

Appl. No.:

11/789275

Inventors:

Thomas Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

Alltech, Inc. - Nicholasville KY

International Classification:

A61K 33/04
A61P 25/16
A61P 25/28

US Classification:

424702000

Abstract:

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX), when administered to a subject, possess the ability to alter (e.g., reduce) gene expression in various tissues (e.g., compared to expression in subjects not administered selenium).

US Patent:

20080286382, Nov 20, 2008

Filed:

May 16, 2008

Appl. No.:

12/122331

Inventors:

Thomas P. Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

ALLTECH, INC. - NICHOLASVILLE KY

International Classification:

A61K 33/04
A61P 15/00

US Classification:

424702

Abstract:

The present invention relates to compositions comprising selenium (e.g., organic selenium (e.g., selenized yeast (e.g., SEL-PLEX))) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment). For example, the present invention provides compositions comprising selenium (e.g., organic selenium (e.g., selenized yeast (e.g., SEL-PLEX))) and methods of using the same for treating and/or preventing one or more conditions (e.g., problems) disorders, and/or diseases related to establishing and/or maintaining a pregnancy. Compositions and methods of the present invention find use in, among other things, research and clinical (e.g., preventative and therapeutic) applications.

US Patent:

20110008466, Jan 13, 2011

Filed:

Jul 9, 2010

Appl. No.:

12/833782

Inventors:

Thomas P. Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

ALLTECH, INC. - Nicholasville KY

International Classification:

A61K 33/04
A61P 25/28
A61P 25/16

US Classification:

424702

Abstract:

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX), when administered to a subject, possess the ability to alter (e.g., reduce) gene expression in various tissues (e.g., compared to expression in subjects not administered selenium).

US Patent:

20110038889, Feb 17, 2011

Filed:

Sep 30, 2010

Appl. No.:

12/895382

Inventors:

Thomas P. Lyons - Nicholasville KY, US
Ronan Power - Lexington KY, US

Assignee:

ALLTECH, INC. - Nicholasville KY

International Classification:

A61K 36/06
A61P 25/28

US Classification:

42419516

Abstract:

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

Address:

14424 S Normal Ave, Riverdale, IL 60827

VIN:

1GNFK13037J230956

Make:

CHEVROLET

Model:

TAHOE

Year:

2007